Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Recruiting 7Unknown 5Not yet recruiting 4Active not recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 296Carcinoma, Hepatocellular 213Stomach Neoplasms 155Pancreatic Neoplasms 155Rectal Neoplasms 114Esophageal Neoplasms 84Colonic Neoplasms 78Esophageal Squamous Cell Carcinoma 52Cholangiocarcinoma 48Liver Neoplasms 47Biliary Tract Neoplasms 36Neoplasms 31Breast Neoplasms 31Neoplasm Metastasis 28Carcinoma, Non-Small-Cell Lung 27Gastrointestinal Neoplasms 26Lung Neoplasms 20Disease 18Prostatic Neoplasms 17Uterine Cervical Neoplasms 16Recurrence 16Ovarian Neoplasms 14Colorectal Neoplasms, Hereditary Nonpolyposis 13Endometrial Neoplasms 12Head and Neck Neoplasms 11Adenocarcinoma Of Esophagus 11Gallbladder Neoplasms 10Colonic Polyps 10Anus Neoplasms 10Melanoma 9

Interventions

zimberelimab 1surufatinib 1Radiosurgery 1Immunotherapy 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Locally Advanced Pancreatic Cancer × Gastrointestinal × Clear all
NCT07429643 2026-02-24

Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.

Assiut University

Phase 2/3 Not yet recruiting
20 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT06669078 2024-11-01

NALIRIFOX

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Not yet recruiting
120 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT05988372 2023-11-01

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

Sun Yat-sen University

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Peking University Third Hospital

Phase 2 Not yet recruiting
96 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡